ABSTRACT The mfluence of HLA mismatches between donor and recipient on the phenotypes, function, and specificity of T-lymphocyte cultures derived from endomyocardial biopsies was studied in 118 heart transplant recipients In case of HLA-DR mismatches, the malorlty of the EMB-derived cultures were dommated by CD4 ÷ T cells while, in patients with HLA-A and -B mismatches but without DR mismatches, CD8 ÷ T cells comprised the predommant T-cell subset Cytotoxiclty against donor antigens was observed in 75% of the cultures A significantly (p < 0 005) lower proportion of the cultures showed cytotoxiclty against HLA-A antigens (36%) when compared with HLA-B (53%) or HLA-DR (49%) An HLA-A2 mismatch elicited a cytotoxlc response that was comparable to that found against HLA-B and -DR antigens 62% of the cultures from HLA-A2 mismatched donor-rec,plent combinations was reactive against A2 A higher number of A, B, or DR mismatches resulted m a higher number of cytotoxlc cultures directed against these antigens A higher number of HLA-B and -DR mismatches was associated with a lower freedom from relection Our data indicate that, despite the use of adequate immunosuppresslve therapy, the degree of HLA matchIng plays a crucial role in the immune response agamst a transplanted heart, resulting m a s,gmficant effect on freedom from re}ection Human Immunology 39, 233-242 (1994 
INTRODUCTION
Products of the tailor hlstocompat,blhty complex (MHC) play a major role m the immune response agamst a transplanted organ [I, 2] In extensive studies m kidney transplant rec~p,ents, a pos~t,ve effect of HLA matchmg on graft survlval was reported, especlally for HLA-B and -DR antigens [3] [4] [5] [6] [7] [8] The beneficial effect of DR matchmg was found to be most evident m the first 233 0198-8859/94/$7 00 postoperative months, while the effect of matching for HLA-B antigens lasted longer These studies were based on the assumption that all of the HLA alleles had the same antigenic weight Busson and coworkers [9] showed, in kidney transplant recipients with only one incompatible HLA-antigen, that some of the HLA-A antigens were associated with a lower transplant survival than others, while at the B locus, there was no significant difference in survival rate among the different antigens
The importance of HLA matching for heart allograft survival is still debated, mainly because of the limited numbers of patients studied and, more importantly, the low numbers of well-matched grafts performed, as donor hearts are randomly allocated without reference to HLA matching Nevertheless, a beneficial effect of HLA matching has been found for cardiac graft survival [ 10, 11] , the incidence of steroid-resistant relectlon [12] , or the freedom from relectlon of the transplanted heart [13] Acute allograft relection is mediated by lmmunocompetent lymphocytes of the graft recipient that interact with allogeneic determinants expressed on the grafted organ Recognition of both HLA class I and class II allogenelc differences by both helper and cytotoxic T lymphocytes (CTLs) precipitates a cascade of reactions that results in a cytotoxic response directed against cells bearing these antigens, and thus In parenchymal damage of the graft tissue [14] [15] [16] [17] [18] [19] [20] In previous studies [21] [22] [23] [24] [25] , we and other showed that graft-infiltrating lymphocytes can be cultured from cardiac graft tissue specimens During acute relection episodes, a higher proportion of these biopsies yielded lymphocyte cultures, of which the maIority was cytotoxic against donor-derived cells
The influence of HLA mismatches between donor and recipient on phenotypes and effector function of graft infiltrating cells has never been systematically studied Therefore we analyzed the effect of HLA-A, -B, and -DR mismatches on the functional and phenotypic characteristics of these cells in a large series of endomyocardIal biopsies (EMBs) from 118 heart transplant recipients Moreover, we investigated the lmmunogenlcIty of individual mismatched HLA antigens
MATERIALS AND METHODS Patients
We studied EMB-derIved graft-infiltrating cells from 118 heart transplant recipients who underwent transplantations between February 1988 and January 1990 All patients had received preoperative blood transfusions and all received cyclosporine and low-dose prednIsone as maintenance lmmunosuppressIon The actuarial patient surwval was 89% at 4 years The mean number of mlsmatches between donor and recipient was 1 25, 1 62, and 1 40 for HLA-A, -B, and -DR, respectively Table  1 shows the distribution of the patients among the dlfferent matched groups HLA hlstocompatiblhty was based on matching for broad specIficitmes Homozygoslties were considered as one mismatched antigen Relectlon was monitored by EMB Grading of the biopsies was according to Bilhnghams [26] criteria of none, mild, moderate, and severe rejection For the diagnosis of moderate relectlon, the coexistence of myocyte necrosis and mononuclear Infiltrates was required In that case, antirejectlon treatment was instituted, which consisted of bolus steroids or, In case of ongoing relectlon, of a 2-week course of a polyclonal rabbit antithymocyte-globuhn preparation There were no cases of severe relectlon In the early posttransplant period, serial biopsy specimens were obtained at weekly intervals Later, EMBs were taken less frequently, declining to once very 4 months at 1 year After an acute relectlon episode, the next biopsy sample was taken 1 week following relectIon therapy Three patients who died within 3 weeks after transplantation (from other causes than severe relectlon) were excluded from this study We received a total of 1285 EMBs, 4-22 from each patient (median, 10)
HLA Typmg
Spleen cells or peripheral blood mononuclear cells (ohtamed by Flcoll separation of heparinlzed blood) were typed for HLA class I antigens according to the standard National Institutes of Health lymphocytotoxlcity assay, and typed for HLA-DR by the two-color fluorescence assay with a set of highly selected antlsera [27] Culture Method Lymphocyte cultures These were established from EMBs as described previously [21] In brief, each biopsy specimen was divided into two or more fragments and placed into two or more wells of a 96-well round-bottom tissue culture plate (Costar 3799, Cambridge, MA, USA) with 200-btl culture medium in the presence of 105 Irradiated (40 Gy) autotogous peripheral blood mononuclear cells as Phenotypm Analysis
The phenotypes of the graft-infiltrating lymphocytes were analyzed by two-color flow cytometry after sta, ning with monoclonal antibo&es &rected against CD8 (ant,-leu2) and CD4 (antl-leu3), both purchased from Becton Dickinson (Mountain Vmw, CA, USA) The annbodms were directly conlugated to fluoresce, n or phycoerythrin A more extensive phenotypic charactenzatmn of the cultured cells is described elsewhere [21] A T-cell subset was considered to be predominant when xt comprised more than 60% of the cells m a culture
Cell-Mediated Cytotoxlclty Assays
Biopsy-derived bulk cultures were tested for donordirected cytotoxlc~ty in a standard 4-hour 5ICr-release assay according to the European Standard Techmque 
Statistical Analysis
The slgmficance of differences among the various groups of panents and cultures was analyzed by Mann-Whitney test or by chl-squared test, respectively Freedom from relectmn rates were computed by actuarial methods and stanstical slgmficance was estimated by log-rank analysis
RESULTS

HLA mlsnaatches and acute re/ectlon
In the DR-matched patient group 56% of pauents remained free from rejecnon at 6 months, compared with 29% of patients with one and 22% with two DR mismatches with thmr donors For the combinatmn of HLA-B and -DR antigens a significant effect on freedom of relectton was observed (p < 0 05, Fig 2) Transplants with two or fewer mismatched HLA-B and -DR antigens displayed a 14% h,gher freedom from relectxon at 6 months compared with those with three or four HLA-B and -DR incompatibilities The number of HLA-A mismatches did not show any addmve effect on freedom from rejection rates No sigmficant relation between the number of acute relecnon episodes and the number of mismatches on the individual A, B, or DR locus was observed HLA mzsmatches and CD4/CD8 phenotypes From all panents, approximately 60% of the EMBs yielded lymphocyte cultures The success of culturing did not depend on the degree of HLA-DR matching between donor and recipient, since the mean percentages growing biopsy specimens were highly comparable m patients with zero, one, or two DR mismatches with their donors (57%, 59%, and 63%, respectively) In the first 180 days after transplantation, the number of HLA-DR mismatches between donor and recipient had a pronounced mfluence on the phenotyplc composltzon of the EMB-derived lymphocyte cultures (Fig 3) Recipients with HLA-A and -B m,smatches but without DR mtsmatches with their donors yielded cultures that were dommated by CD8 + T cells m 60% of cases (p < 0 005 compared with DRmismatched combinattons) In cultures from patients wzth DR mismatches, CD4 ÷ T cells comprised the predommant T-cell subset The predommance of CD4 ÷ T cells was most ewdent m patients with two DR mismatches with their donors (p = 0 025 compared with DR-matched combmatmns) After the first 6 posttransplant months, no slgmficant differences between the groups were found The mfluence of the degree of HLA class I matchmg on growth and phenotyplc composltlon of the cultures was hard to evaluate, because all patients except one had one or more class I mlsmatches The EMB-denved cultures (n = 7) from this stogie patient were all dominated by CD4 + T cells In the remainmg patlents, no slgnIf- Cytotoxlczty In vitro studies showed that the malority (n = 234 or 75%) of the tested EMB-derlved T-lymphocyte cultures (n = 324) was cytotoxlc against donor antigens Of these cultures, 165 (53%) and 154 (49%) were cytotoxlc against HLA-B and -DR antigens, respectlvely Significantly fewer cultures (n = 107, 36%, p < 0 005) showed cytotoxlclty against HLA-A antigens This higher immunogentclty of HLA-B and -DR antigens was also apparent when we analyzed the CTL reactivity against several individual HLA antigens (Table 2) This was analyzed for broad specifiCltles and not splits Agamst most HLA-A antigens a low percentage of reactive cultures was found Only HLA-A2 was found to be of comparable immunogeniclty to HLA-B and -DR antigens Of the 90 tested cultures from 23 donorrecipient combinations with an HLA-A2 incompatibility, 62% showed reactivity against A2, which was significantly higher than generally found against other HLA-A antigens (p < 0 001, Table 2 ) When analyzed as the percentage reactive cultures for each individual patient, a median of 60% HLA-A2-reactlve cultures was found, which was agam significantly higher than against other m~smatched HLA-A antigens (p < 0 001, Fig 4) Among the HLA-B antigens, no evidence for such an immunodominant locus allele was found Generally, a high percentage of tested cultures showed cytotoxlclty agamst mismatched HLA-B antigens, while against some of these antigens the reactwlty was lower (Tables 2  and 3 ) A slmflar pattern was found for reactivity agamst HLA-DR mismatches (Table 3) In time, donor-directed cytotoxiclty declined significantly (p < 0 03), from 79% (181 of 229) of the cultures established from EMB taken in the first 180 days to 61% (58 of 95) after 6 months This was due to a fall in the percentage of cultures that were cytotoxtc against mismatched donor HLA-B and -DR antigens (Table 4) A higher number of HLA-A, -B, or -DR mismatches between donor and recipient was found to be positively correlated with the percentage of cytotoxtc cultures directed against these antigens (Table 5 ) Biopsy samples from patients with two A, B, or DR mismatches with their donors yielded a higher proportion of cytotoxlc cultures directed against these antigens when compared with EMB from patients who had only one mismatch for any of these HLA antigens The pronounced dose effect of HLA-A mismatches was mainly found when the second HLA-A anngen was A2 (in 62% of cultures from donor-recipient combinations with two HLA-A mismatches and a positive CML against HLA-A, compared FIGURE 2 Actuarial freedom from relectlon of heart transplants in relation to matching for HLA-B and -DR antigens The freedom from rejecnon of patients with ~<2 or >3 mismatches for the combined B and DR antigens were 65°~ and 42% at 2 months (p = 0 01), and 37% and 24% at 6 months (p = 0 05), respectively with only 28% of cultures not reactive against HLA-A, p < 0001, X 2test)
DISCUSSION
The present study shows that the number of mismatched HLA-B and -DR antigens on a transplanted heart, but also HLA-A antigens, is positively correlated with the percentage of cytotoxlc EMB-dertved cultures directed against these mismatched HLA antigens The incidence of HLA-A-dlrected cytotoxictty was lower, however, than that directed against B or DR mismatches This apparently high tmmunogemcity of HLA-B and -DR antigens may account for the significantly lower freedom from relection rates In the patient group with more than two HLA-B and -DR mismatches This association between the number of HLA-B and -DR mismatches and freedom from relectton has also been described by others FIGURE 3 Predominant phenotype of EMB-derlved lymphocyte cultures an relation to the number of HLA-DR mismatches (MM) between donor and recipient In the first 180 days after transplantation, cultures from patients without DR mismatches with their donors were most often dominated by CD8 + cells (p < 0 005 compared with DR-matched combinations), while in cultures from patients with DR mismatches CD4 ÷ T cells comprised the predominant subset In the malority of cultures (left) After the first 6 posttransplant months, no significant differences between the groups were found (right) Numbers of cultures tested (left) 0 DR MM (n = 22), 1DRMM(n = 160), and2DRMM(n = 226),and (right) 0DRMM(n ~-17), 1DRMM(n = 106), and 2 DR MM (n = 110) relation between pretransplant CTLp frequencies and transplant outcome has not been shown But ~t was found in mice that an mcrease of CTLp frequency after transplantation is associated with allograft relectlon [35] In renal transplant patients, a decrease of donorspecific CTLp is correlated with good graft function [36] , and a low patient-specific CTLp frequency in a bone marrow donor glves less graft-versus-host d~sease [37] In the present study, a "dose-effect" phenomenon of the number of mismatches on CML reactivity was found for HLA-A, -B, and -DR antigens This dose--effect phenomenon of HLA mismatches could also be observed m the higher 6-month freedom from relectlon m patients with two or fewer HLA-B and -DR mlsmatches m the 
DR MISMATCHES
first half year This is consistent wlth data of Opelz [3, 10, 38] , who showed that during the early posttransplant course, HLA-B and -DR mismatches exerted a strong mfluence on transplant survival, m contrast to mismatched HLA-A antigens However, the mfluence of the latter on long-term survival was comparable to that of Interestingly, the dose effect for HLA-A mismatches was mainly found when the second mismatched antigen on the A locus was A2 Our finding of hlgh reactivity against HLA-A2 antigens expressed on donor cells confirms the observation of others [33] (Roelen, personal commumcation) that HLA-A2 is an immunodomlnant locus allele They found high anti-A2 CTLp frequencies among normal mdlvlduals and m hlghly sensitized patients awaiting renal transplantation, respectively By Inhibition experiments w~th CD8 monoclonal antibodies, it was shown that all antl-HLA-A (lncludmg A2) CTLps could be inhibited, lndlcatmg that these cytotoxlc T cells have a low avldlty for HLA-A antlgens Of HLA-B-dlrected CTLs, slgmficantly fewer could be mhlblted In previous reports [39, 40] , we have shown that low-awdlty alloreactwe CTLs are probably not relevant for the rejection process Hlgh-awdlty alloreactlve CTLs can be demonstrated in the peripheral blood of highly sensltlzed candldates for renal (re)transplantation, and xn the grafts of relectmg heart transplant recipients Interestingly, prehmmary data from Eurotransplant (Thorogood) show In the first half-year,the incidence of HLA-A-&rected cytotoxlclty was slgmficantly lower than that agamst B or DR anngens (p < 0 001)
Number and percent of reacnve cultures h X2 test that a mismatch for HLA-A2 does not result m a lower kidney transplant survival In the present study, this could not be evaluated, because all panents also had several HLA-B and -DR mismatches with thmr donors
In the one and two DR-mismatched groups, slgmficantly more CD4-dommated cultures were derived from the bmpsles than in the DR-matched group CD4 + cells are known to be of crucial importance m the lnmatmn of rejecuon [14] [15] [16] [17] [18] [19] [20] Interacuon of these cells with donor class II MHC anngens expressed on the graft nssue and on passenger leukocytes of donor ongm results in acnvanon of CD8 + cells that recognize MHC class I anugens Both CD4 + and CD8 + cells play a role m the relecuon of mismatched grafts [14] [15] [16] Relecnon of class I &sparate grafts appears to depend most on CD8 + cells, although CD4 + cells can be acnvated as well via presentatmn of donor MHC class I anngens on rec~p,ent antigen-presenting cells m the context of self-HLA class II molecules [41, 42] More than 180 days after transplantation, the dechne found m the number of the CD4-dommated cultures may be due to a lower expression of donor-type class II antigens on graft nssue, due to the replacement of donor dendritic cells by the pauents' antigen-presenting cells [43, 44] As a consequence, fewer class-II-speclfic CD4 + lymphocytes may be attracted to the graft Data from ammal heart transplant models show that this reductmn of the number of HLA class-II-expressmg dendntlC cells may already start early after transplantatmn, wh,ch may explain our finding that m some patients an earher dechne of DR-&rected cytotoxmlty is found [45] (data not shown)
Lower expressmn of donor-type HLA antigens on graft t~ssue may also play a role in the lower incidence of cytotoxlc,ty &rected against these antigens after 6 [47, 48] Next to the mfluence of HLA expression on the graft, other mechanisms may also be involved Spec,fic suppressmn of antldonor responses by regulatory T cells, clonal anergy or deletmn of ant,donor T cells, or downmodulatmn by anmdmtyp,c ant,bodies are thought to be important mechamsms contribut,ng to acquired immune tolerance ,n human transplant rec,p> ents [21, 36, [48] [49] [50] In conclusmn, we showed that the number and nature of HLA mismatches between donor and rec,p,ent strongly mfluence the cellular ,mmune response w,thm the transplanted heart, resultmg in a s,gnificant effect on freedom from relectmn 26 Billingham ME Diagnosis of cardiac relection by endomyocardial biopsy J Heart Transplant 1 25, 1982 
